Myelodysplastic Syndromes
Showing NaN - NaN of 103
Leukemia, Myeloid, Acute, MDS, Leukemia, Myelomonocytic, Chronic Trial in Worldwide (H3B-8800 (RVT-2001))
Recruiting
- Leukemia, Myeloid, Acute
- +2 more
- H3B-8800 (RVT-2001)
-
Stanford, California
- +26 more
Mar 23, 2022
MDS, Secondary Acute Myeloid Leukemia (AML) Trial in United States (Clofarabine)
Completed
- Myelodysplastic Syndromes
- Secondary Acute Myeloid Leukemia (AML)
-
Chicago, Illinois
- +5 more
Mar 15, 2022
Leukemia, Myeloid, Acute, MDS Trial in Worldwide (CC-95251, Azacitidine)
Recruiting
- Leukemia, Myeloid, Acute
- Myelodysplastic Syndromes
-
Marina Del Rey, California
- +35 more
Mar 11, 2022
Acute Myeloid Leukemia, MDS Trial in United States (CG-806)
Recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
-
Duarte, California
- +9 more
Mar 4, 2022
Acute Myeloid Leukemia, MDS Trial in Worldwide (Bemcentinib, Cytarabine, Decitabine)
Active, not recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- Bemcentinib
- +2 more
-
Iowa City, Iowa
- +11 more
Mar 1, 2022
MDS Trial in Worldwide (Luspatercept, Placebo)
Leukemias, MDS Trial in Houston (sapacitabine)
Completed
- Leukemias
- Myelodysplastic Syndromes
-
Houston, TexasThe University of Texas MD Anderson Cancer Center
Dec 7, 2021
Acute Myeloid Leukemia, Acute Lymphoid Leukemia, MDS Trial in United States (TregGraft (Orca-T))
Recruiting
- Acute Myeloid Leukemia
- +4 more
- TregGraft (Orca-T)
-
Duarte, California
- +13 more
Oct 28, 2021
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, MDS Trial in United States (OrcaGraft (Orca-Q))
Recruiting
- Acute Myeloid Leukemia
- +3 more
- OrcaGraft (Orca-Q)
-
Duarte, California
- +7 more
Oct 28, 2021
MDS, Leukemia, Myelomonocytic, Chronic Trial in Worldwide (Guadecitabine, Treatment Choice)
Completed
- Myelodysplastic Syndromes
- Leukemia, Myelomonocytic, Chronic
- Guadecitabine
- Treatment Choice
-
Duarte, California
- +95 more
Sep 1, 2021
MDS, Iron Overload Trial in Stanford, Detroit, Houston (Deferasirox)
Completed
- Myelodysplastic Syndromes
- Iron Overload
-
Stanford, California
- +2 more
Jun 1, 2021
MDS Trial in France, Germany, United States (Oral rigosertib)
Completed
- Myelodysplastic Syndromes
- Oral rigosertib
-
Stanford, California
- +13 more
Jun 15, 2021
Acute Myeloid Leukemia, in Relapse, MDS Trial in Australia, United States (CB-5339)
Recruiting
- Acute Myeloid Leukemia, in Relapse
- Myelodysplastic Syndromes
-
Scottsdale, Arizona
- +8 more
May 17, 2021
Quality of Life and Symptoms in Newly Diagnosed Myelodysplastic
Active, not recruiting
- Adult
- Myelodysplastic Syndromes
- questionnaire administration
- +3 more
-
New York, New York
- +52 more
Dec 21, 2020
MDS Trial in Worldwide (Deferasirox, Placebo)
Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Spartanburg, Houston (methadone HCl, morphine
Terminated
- Brain and Central Nervous System Tumors
- +10 more
- methadone hydrochloride
- +2 more
-
Spartanburg, South Carolina
- +1 more
Sep 1, 2020
MDS Trial in United States (ARRY-614, p38/Tie2 inhibitor; oral)
Completed
- Myelodysplastic Syndromes
- ARRY-614, p38/Tie2 inhibitor; oral
-
Tampa, Florida
- +3 more
Sep 4, 2020
MDS Trial in Tampa, Atlanta, Houston (ARRY-614, p38/Tie2 inhibitor; oral)
Completed
- Myelodysplastic Syndromes
- ARRY-614, p38/Tie2 inhibitor; oral
-
Tampa, Florida
- +2 more
Sep 4, 2020
MDS, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in Worldwide (Panobinostat (LBH589), 5-Azacytidine)
Completed
- Myelodysplastic Syndromes
- +2 more
- Panobinostat (LBH589)
- 5-Azacytidine
-
Augusta, Georgia
- +37 more
Jul 20, 2020
MDS, Refractory Anemia With Excess Blasts, Chronic Myelomonocytic Leukemia Trial in Worldwide (rigosertib sodium)
Completed
- Myelodysplastic Syndromes
- +3 more
- rigosertib sodium
-
Stanford, California
- +34 more
Jun 29, 2020
MDS, MDS, RAEB Trial in Worldwide (ON 01910.Na)
Completed
- Myelodysplastic Syndromes
- +3 more
- ON 01910.Na
-
Scottsdale, Arizona
- +86 more
Jun 29, 2020
MDS Trial in Germany, United States (lenalidomide)
Completed
- Myelodysplastic Syndromes
-
Scottsdale, Arizona
- +31 more
Nov 6, 2019
MDS Trial in United States (Atezolizumab, Azacitidine)
Completed
- Myelodysplastic Syndromes
-
Duarte, California
- +14 more
Aug 15, 2019